Chronotherapy in Ulcerative Colitis

The purpose of this study is to evaluate if time of day administration of oral, once daily 5-ASA therapy in alignment with a patient’s circadian rhythms will improve the patient’s condition. The study will use signs of inflammation, how easily substances are absorbed into your bloodstream (gut permeability), microbiome community (the bacteria in your gut), and measured levels of 5-ASA in your blood stream to determine if time of 5-ASA administration alters a patient’s condition.

In order to participate you must meet the following criteria:

• Are an adult with ulcerative colitis currently taking 5-ASA (5-Aminosalicylic Acid).

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.